HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

HF-TAC

structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Altamimi, Tariq R: 1 article (01/2019)
2.	Joerg, Alice R: 1 article (01/2019)
3.	Johnstone, David E: 1 article (01/2019)
4.	Karwi, Qutuba G: 1 article (01/2019)
5.	Lopaschuk, Gary D: 1 article (01/2019)
6.	Oudit, Gavin Y: 1 article (01/2019)
7.	Padwal, Raj S: 1 article (01/2019)
8.	Patel, Vaibhav: 1 article (01/2019)
9.	Sharma, Arya: 1 article (01/2019)
10.	Uddin, Golam M: 1 article (01/2019)

Related Diseases

1.	Weight Loss (Weight Reduction) 01/01/2019 - "Weight loss improved cardiac function (%EF was 38 ± 6% and 36 ± 6% in HF TAC LF and HF TAC CR mice vs 25 ± 3% in HF TAC mice, P < 0.05) and it decreased cardiac hypertrophy post TAC (left ventricle mass was 168 ± 7 and 171 ± 10 mg in HF TAC LF and HF TAC CR mice, respectively, vs 210 ± 8 mg in HF TAC mice, P < 0.05). " 01/01/2019 - "Obese mice with heart failure were then switched for 8 weeks to either a low-fat (LF) diet (HF TAC LF) or caloric restriction (CR) (40% caloric intake reduction, HF TAC CR) to induce weight loss. " 01/01/2019 - "Weight loss enhanced cardiac insulin signalling, insulin-stimulated glucose oxidation rates (1.5 ± 0.1 and 1.5 ± 0.1 μmol/g dry wt/min in HF TAC LF and HF TAC CR mice, respectively, vs 0.2 ± 0.1 μmol/g dry wt/min in HF TAC mice, P < 0.05) and it decreased pyruvate dehydrogenase phosphorylation. "
2.	Cardiomegaly (Heart Hypertrophy) 01/01/2019 - "Weight loss improved cardiac function (%EF was 38 ± 6% and 36 ± 6% in HF TAC LF and HF TAC CR mice vs 25 ± 3% in HF TAC mice, P < 0.05) and it decreased cardiac hypertrophy post TAC (left ventricle mass was 168 ± 7 and 171 ± 10 mg in HF TAC LF and HF TAC CR mice, respectively, vs 210 ± 8 mg in HF TAC mice, P < 0.05). "
3.	Heart Failure 01/01/2019 - "Obese mice with heart failure were then switched for 8 weeks to either a low-fat (LF) diet (HF TAC LF) or caloric restriction (CR) (40% caloric intake reduction, HF TAC CR) to induce weight loss. "

Related Drugs and Biologics

1.	Pyruvic Acid (Pyruvate)
2.	Oxidoreductases (Dehydrogenase)
3.	Insulin (Novolin)
4.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Caloric Restriction